Incobotulinumtoxin a
Products billed under this code include Xeomin.
Payment limit per 1 UNIT, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Xeomin.
Payment limit per 1 UNIT, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Xeomin | Merz Pharmaceuticals, LLC | 00259-1605-01 | 50 | $263.10 |
| Xeomin | Merz Pharmaceuticals, LLC | 00259-1610-01 | 100 | $526.20 |
| Xeomin | Merz Pharmaceuticals, LLC | 00259-1620-01 | 200 | $1,052.40 |
| Xeomin | Merz North America, Inc. | 46783-0160-01 | 100 | $526.20 |
| Xeomin | Merz North America, Inc. | 46783-0161-01 | 50 | $263.10 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $5.262 | −$0.023 | 1 UNIT | Incobotulinumtoxin a | v1, posted September 17, 2026 |
| 3Q26 | $5.285 | −$0.004 | 1 UNIT | Incobotulinumtoxin a | v1, posted September 15, 2026 |
| 2Q26 | $5.289 | +$0.035 | 1 UNIT | Incobotulinumtoxin a | v1, posted September 15, 2026 |
| 1Q26 | $5.254 | −$0.041 | 1 UNIT | Incobotulinumtoxin a | v1, posted September 15, 2026 |
| 4Q25 | $5.295 | −$0.012 | 1 UNIT | Incobotulinumtoxin a | v1, posted September 8, 2026 |
| 3Q25 | $5.307 | −$0.023 | 1 UNIT | Incobotulinumtoxin a | v1, posted March 10, 2026 |
| 2Q25 | $5.33 | +$0.025 | 1 UNIT | Incobotulinumtoxin a | v1, posted March 10, 2026 |
| 1Q25 | $5.305 | −$0.033 | 1 UNIT | Incobotulinumtoxin a | v1, posted December 19, 2025 |
| 4Q24 | $5.338 | +$0.132 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 11, 2025 |
| 3Q24 | $5.206 | +$0.009 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 11, 2025 |
| 2Q24 | $5.197 | +$0.011 | 1 UNIT | Incobotulinumtoxin a | v1, posted March 11, 2025 |
| 1Q24 | $5.186 | −$0.003 | 1 UNIT | Incobotulinumtoxin a | v1, posted December 19, 2024 |
| 4Q23 | $5.189 | −$0.007 | 1 UNIT | Incobotulinumtoxin a | v1, posted October 10, 2024 |
| 3Q23 | $5.196 | −$0.005 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 5, 2024 |
| 2Q23 | $5.201 | +$0.064 | 1 UNIT | Incobotulinumtoxin a | v1, posted February 23, 2024 |
| 1Q23 | $5.137 | +$0.085 | 1 UNIT | Incobotulinumtoxin a | v1, posted December 6, 2023 |
| 4Q22 | $5.052 | −$0.006 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 22, 2023 |
| 3Q22 | $5.058 | −$0.005 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 9, 2023 |
| 2Q22 | $5.063 | +$0.005 | 1 UNIT | Incobotulinumtoxin a | v1, posted December 14, 2022 |
| 1Q22 | $5.058 | +$0.011 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 8, 2022 |
| 4Q21 | $5.047 | +$0.003 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 2, 2022 |
| 3Q21 | $5.044 | −$0.015 | 1 UNIT | Incobotulinumtoxin a | v1, posted June 2, 2022 |
| 2Q21 | $5.059 | +$0.004 | 1 UNIT | Incobotulinumtoxin a | v1, posted March 1, 2022 |
| 1Q21 | $5.055 | – | 1 UNIT | Incobotulinumtoxin a | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.